retatrutide triple agonist gip glp-1 glucagon Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide Explained: The Triple Agonist

Everyone in need of daily sun protection with skincare benefits

Thyroid hormones, including thyroxine (T4) and triiodothyronine (T3), play a vital role in regulating metabolism and energy production in the body

Animal research suggests these medications increase amount of deep sleep and reduce sleep latency in mice

Researchers are exploring nanotechnology-based medication delivery systems to improve renal treatment, addressing traditional drawbacks like stability, solubility, and toxic effects, making NPs a promising tool for disease diagnosis and treatment 26

Carnitine is a vital substance for energy production in the body